HOME > TOP STORIES
TOP STORIES
-
BUSINESS Damage Suit Filed over HPV Vaccines; MSD Says Claims Scientifically Unfounded
July 28, 2016
-
REGULATORY MHLW to Canvass Drug Makers’ Opinions on Real-World Roles of “3 Key Officers”: Pharma Safety Head
July 27, 2016
-
REGULATORY ICH Clinical Trial Guidelines Allow Flexibility on Number of Japanese Subjects Needed: PMDA Official
July 26, 2016
-
REGULATORY MRSA Infections Add 190 Billion Yen Annually to Medical Expenditure at DPC Hospitals: MHLW Study Group
July 25, 2016
-
ACADEMIA Japanese Society of Nephrology Aims to Promote Development through “Surrogate Endpoints”; Hopes to Draft Guidelines in FY2017
July 22, 2016
-
REGULATORY PMDA to Announce Evaluation Policy on Diagnosis Using Next-Generation Sequencers
July 21, 2016
-
ACADEMIA New Atherosclerosis Guidelines Likely to Add PCSK9 Inhibitors for Primary Prevention of CAD in Familial Hypercholesterolemia
July 20, 2016
-
REGULATORY CDISC Therapeutic Area Standards “Can Be Used in Japan”: MHLW Study Group
July 19, 2016
-
REGULATORY Generics Should Vie on “Quality and Attractiveness”: MHLW Pharma Bureau Chief
July 15, 2016
-
REGULATORY More Companies Interested in Supporting Academia Research from the Seeds Stage: AMED Official
July 14, 2016
-
REGULATORY MHLW to Set Prerequisites for Patients, Physicians to Optimize Innovative Drug Use: Pharma Bureau Chief
July 13, 2016
-
REGULATORY AMED Aims to Facilitate Drug Makers’ Access to Knowledge at Research Institutions: President
July 12, 2016
-
REGULATORY MHLW to Put Expensive Drug Issue Up for Chuikyo Discussion ASAP: Medical Economics Division Chief
July 11, 2016
-
REGULATORY “New Rules” for Expensive Drugs Could Impact Business Models: Health Insurance Bureau Chief
July 8, 2016
-
BUSINESS Kyorin Anticipates Annual Growth of “at Least 3%” through New Drugs Despite Patent Loss for Kipres: President
July 7, 2016
-
BUSINESS Delving into Securities Filings - 3: Six Companies Report Higher Pay, More Employees
July 6, 2016
-
BUSINESS Delving into Securities Filings - 2: Average Annual Pay at 3 Generic Majors Tops 7 Mil. Yen
July 5, 2016
-
BUSINESS Delving into Securities Filings - 1: 1st and 2nd-Tier Makers Continue to Shed Jobs as Generic Peers See Rise in Workforce
July 4, 2016
-
BUSINESS Filing for 1st Japan-Made Nucleic Acid Expected by Year-End If PIII Yields Positive Data
July 1, 2016
-
BUSINESS Nichi-Iko Aims for 20% Share of Generic Market in “80% Generic Era”: President
June 30, 2016
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
